Suspension compositions of multi-target inhibitors

This disclosure relates to aqueous suspension formulations of multi-target inhibitors. These formulations can be locally administered to target tissues such as eyes, prostate, that may be solved by the present disclosure are to (1) provide an injectable dosage form that allows direct delivery of a m...

Full description

Saved in:
Bibliographic Details
Main Authors DING SHULIN, TANG-LIU DIANE, MUHURI GOUTAM
Format Patent
LanguageChinese
English
Published 02.10.2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:This disclosure relates to aqueous suspension formulations of multi-target inhibitors. These formulations can be locally administered to target tissues such as eyes, prostate, that may be solved by the present disclosure are to (1) provide an injectable dosage form that allows direct delivery of a multi-target inhibitor to the proximity of the diseased tissue, (2) be compatible with the tissue ofthe site of administration, (3) form a drug reservoir at the administration site to allow prolonged supply of the drug to the diseased tissue, and thus reduce dosing frequency, (4) the release rate ofthe drug from the reservoir is such that above therapeutic level of the drug in the diseased tissue is achievable, (5) have physicochemical properties that are suitable for clinical uses, (6) be terminally sterilizable so that safety risk due to contamination of micro-organisms can be minimized, and (7) have a stability profile suitable for long term storage and distribution. 本公开涉及多靶抑制剂的水性悬浮液制剂。这些制剂可以局部施用于靶组织,例如眼睛、前列腺,本公开
Bibliography:Application Number: CN201980008927